BioLineRx
BLRX
$4.38
Share price
-9.86%
Change (1 day)
256.11%
Change (1 year)
Categories
Revenue for BioLineRx (BLRX)
Revenue in 2024 (TTM): A$32.76 Million
According to BioLineRx's latest financial reports the company's current revenue (TTM 
) is A$36.37 Million. In 2023 the company made a revenue of A$7.04 Million an increase over the revenue in the year 2022 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for BioLineRx from 2010 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 (TTM) | A$32.76 M | 365.1% |
| 2023 | A$7.04 M | |
| 2022 | N/A | |
| 2021 | N/A | |
| 2020 | N/A | |
| 2019 | N/A | |
| 2018 | N/A | |
| 2017 | N/A | |
| 2016 | N/A | |
| 2015 | N/A | |
| 2014 | N/A | |
| 2013 | N/A | |
| 2012 | N/A | |
| 2011 | N/A | -100% |
| 2010 | A$31.39 M |